MMP9 and breast carcinoma: In particular, cyanidin-3-O-sambubioside and delphinidin lowered the expression of phospho-Akt or blocked the MAPK signaling pathway, inducing a decrease in MMP-9 and leading to the inhibition of the metastatic processes in breast cancer cells [181,182].